Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
For the first time, the removal process of metronidazole (MNZ) from aqueous solutions over nano zerovalent iron (NZVI) encapsulated within poly(acrylic acid) (
PAA
)/poly(vinylidene fluoride) (PVDF) membranes was reported. The resultant composite (
PPN
) demonstrated high reactivity, excellent stability and reusability over the reaction course. Such excellent performance might be attributed to the presence of the charged carboxyl groups in PVDF membrane support, which could enhance NZVI dispersion and improve its longevity. Results showed that a lower initial concentration and higher reaction temperature facilitated the removal of MNZ by
PPN
, and that the acidic and neutral conditions generally exhibited more favorable effect on MNZ removal than the alkaline ones. Kinetics of the MNZ removal by
PPN
was found to follow a two-parameter pseudo-first-order decay model well, and the activation energy of the MNZ degradation by
PPN
was determined to be 30.49kJ/mol. The presence of chloride ions slightly enhanced the reactivity of
PPN
with MNZ, whereas sulfate ions inhibited its reactivity. In addition, MNZ degradation pathways by
PPN
were proposed based on the identified intermediates. This study suggests that
PPN
composite possessing excellent performance may be a promising functional material to pretreat antibiotic wastewaters.
...
PMID:Investigation of PAA/PVDF-NZVI hybrids for metronidazole removal: synthesis, characterization, and reactivity characteristics. 2431 46